CLINICAL_TRIALS
trial_result
· 2022-10-17
Clinical Trial Update: Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis [Phase 2]
Summary
Phase 2 trial evaluating PRT-2761 for allergic conjunctivitis has been completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ORA, Inc. | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2022-10-17